Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Vale

Showing results (491-500 of 830) with videos related to

Pageof 83
Sort By:
Journal of Medicinal Chemistry|March 3, 1999
Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutionsL Cervini, P Theobald, A Corrigan, et al.
Endocrinology|March 31, 1999
Activin and inhibin binding to the soluble extracellular domain of activin receptor IIC J Donaldson, J M Vaughan, A Z Corrigan, et al.
Endocrine Research|January 1, 1984
Effects of the (imBzl)D-His6, Des-Gly analog of GnRH on gonadotropin and estradiol secretion in normal womenJ DeFazio, J K Lu, W Vale, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1982
"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosisD R Meldrum, R J Chang, J Lu, et al.
Journal of Medicinal Chemistry|March 26, 1998
Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studiesL A Cervini, C J Donaldson, S C Koerber, et al.
Endocrinology|February 1, 1992
Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrierD Jezová, V Bartanusz, I Westergren, et al.
The New England Journal of Medicine|September 17, 1981
Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptiveR Linde, G C Doelle, N Alexander, et al.
American Journal of Obstetrics and Gynecology|November 15, 1983
A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogueM Filicori, D A Hall, J S Loughlin, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 1999
Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptorsM H Perrin, S W Sutton, L A Cervini, et al.
Journal of Endocrinological Investigation|August 1, 1987
Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1-40-OH in manJ A Goldman, M E Molitch, M O Thorner, et al.
Pageof 83

Showing results (491-500 of 830) with videos related to

Sort By:
Pageof 83
Journal of Medicinal Chemistry|March 3, 1999
Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutionsL Cervini, P Theobald, A Corrigan, et al.
Endocrinology|March 31, 1999
Activin and inhibin binding to the soluble extracellular domain of activin receptor IIC J Donaldson, J M Vaughan, A Z Corrigan, et al.
Endocrine Research|January 1, 1984
Effects of the (imBzl)D-His6, Des-Gly analog of GnRH on gonadotropin and estradiol secretion in normal womenJ DeFazio, J K Lu, W Vale, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1982
"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosisD R Meldrum, R J Chang, J Lu, et al.
Journal of Medicinal Chemistry|March 26, 1998
Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studiesL A Cervini, C J Donaldson, S C Koerber, et al.
Endocrinology|February 1, 1992
Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrierD Jezová, V Bartanusz, I Westergren, et al.
The New England Journal of Medicine|September 17, 1981
Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptiveR Linde, G C Doelle, N Alexander, et al.
American Journal of Obstetrics and Gynecology|November 15, 1983
A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogueM Filicori, D A Hall, J S Loughlin, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 1999
Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptorsM H Perrin, S W Sutton, L A Cervini, et al.
Journal of Endocrinological Investigation|August 1, 1987
Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1-40-OH in manJ A Goldman, M E Molitch, M O Thorner, et al.
Pageof 83